Latest Conference Articles

The use of interferon to treat hepatitis C infections has fallen out of favor with the advent of new antivirals and drug combinations that have fewer side effects. But in a study presented at the 2015 International Liver Congress in Vienna, Austria, researchers from the UK said that physicians should put interferon back on the treatment menu.

The assumption used to be that after a liver transplant patients would need to take immunosuppressive drugs for years, even for life. A team of German researchers say that for about half of adult patients, that is no longer true.

In this video interview, Camille Barrault, MD, spoke about the implications her work with baclofen could have for the future of liver disease research at The International Liver Congress 2015, Vienna, Austria.

As good news about new treatments for hepatitis C infections continues to dominate the 2015 International Liver Congress, Texas researchers today reported more success with sofosbuvir and daclatasvir.

One cure for polycystic liver disease is a liver transplant-but since the disease is not fatal (the liver continues to do its job despite the problems the condition causes for patients), physicians face a treatment dilemma. A Belgian team offers an objective way to make the decision.

Video Interview: Vinood Patel, PhD, PGCHE, fHEA, FRSC, University of Westminster, London, UK, shared valuable insight regarding chronic alcoholic demographics and biomarkers on the horizon at The International Liver Congress 2015.

A new antiviral combination is showing promise in treating patients with both chronic kidney disease and chronic hepatitis C, Texas researchers reported at the International Liver Congress in Vienna, Austria.

Video Interview: Camille Barrault, MD discussed how her experiences with alcohol dependent patients correlated with her team's current research at The International Liver Congress 2015, Vienna, Austria.

When it comes to developing heart disease, patients who have non-alcoholic steatohepatitis (NASH) liver disease are at greater risk of both cardiovascular illness and death than patients with non-alcoholic fatty liver disease a UK team reported today at the International Liver Congress in Vienna, Austria.

Researchers in India have found a reliable and sensitive marker to predict how close to organ failure seriously ill patients with liver disease may be.

In the past year there has been a large amount of discussion about the best ways to treat stroke patients. While operations have become more accepted there are other less invasive steps that can be taken as well.

Active immunization for hepatitis B can be a cheaper, safe way to prevent infections that occur when liver transplant recipients are infected by donors' organs.

After partial hepatectomy, the liver does not need an environment rich in microbes and microbial products to regenerate, a Swiss team reports. The finding contradicts earlier studies.

You can tell a lot about a person by the way they walk, the way they sit, and the way they conduct themselves in general. Recent research has also shown that signs of potential health issues can be seen when watching a person move.

French researchers found that patients with hepatitis C infections due to genotypes 4 and 5 did well on a combination of ledipasvir and sofosbuvir (Harvoni/Gilead.) The drug got FDA approval last year but since then there have been few reports on how well it is doing in the real world.

When it comes to headaches many people are familiar with the pain of migraines but cluster headaches can have just as much if not more of an impact on a person's life.

A new antiviral combination that shows dramatic results in getting a response from patients with both chronic kidney failure and hepatitis C is proving versatile.

Video Interview: Palak Trivedi, BSc, MBBS, MRCP, University in Birmingham, England, spoke about several drug candidates under review working to improve outcomes of liver blood tests at The International Liver Congress 2015, Vienna, Austria.

Translational medicine should work for many patients with liver cancer, a French research team reported this morning at the 2015 International Liver Congress.

In this video interview, Palak Trivedi, BSc, MBBS, MRCP, from the University of Birmingham Centre for Liver Research, United Kingdom, discussed the implications his research findings have for IBD patients at The International Liver Congress 2015 in Vienna, Austria.

So far there are no approved pharmaceuticals for treating a common liver disease, non-alcoholic steatohepatitis (NASH). But in a second encouraging drug development reported at the International Liver Congress in Vienna, Austria this morning, Austria, researchers said they like what they see in a trial of Liraglutide (Saxenda/ NovoNordisk).

An investigational diabetes drug called remogliflozin etabonate appears to also show promise for treating a common liver disease, non-alcoholic steatohepatitis (NASH) and its precursor non-alcoholic fatty liver disease (NAFLD).

High levels of vitamin D3 appear to induce weight gain in mice that were fed a high-fat diet, a research team found.

Many studies have looked at the link between vitamin D deficiency and liver disease. A Korean team recently examined whether vitamin D deficiency played a pivotal role in abnormal liver enzymes.

The intracellar lipid deposition, mitrochondrial dysfunction, and insulin resistance associated with non-alcoholic fatty liver disease is likely regulated by microRNAs, particularly in obese patients.

Patients with severe cirrhosis, those who are waiting for a liver transplant, or have recurrent hepatitis C infection following treatment are desperately ill. Researchers at the 2015 International Liver Congress reported that a fixed dose combination of ledipasvir/sofosbuvir given in combination with ribavirin helped many of these patients, according to the results from the SOLAR 2 trial.

To the legal and criminal justice system, people with behavioral-variant frontotemporal dementia (bvFTD) are responsible for any moral or legal transgressions questions that assumption.

Stroke episodes are ideally suited for assessing the concept of value-based care, a Kentucky team argues.

With all the focus on the hazards of concussion brain injury in professional US football, Australian researchers decided it was time to take a look at the risks in rugby.

A diet rich in fish, green leafy vegetables, nuts and whole grains appears to lead to an increase in brain volume.